ProKidney has lower quarterly loss, progress on key studies

ProKidney Corp. reported Monday a slightly lower third-quarter loss as the Winston-Salem biopharmaceutical manufacturer continues its pursuit of a breakthrough drug therapy for patients experiencing advanced chronic kidney disease.